[
  {
    "date": "2023-12-30",
    "symbol": "ATNM",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 76677000,
    "prepaidexpenseandotherassetscurrent": 1586000,
    "assetscurrent": 78263000,
    "propertyplantandequipmentnet": 550000,
    "restrictedcashnoncurrent": 313000,
    "operatingleaserightofuseasset": 2289000,
    "financeleaserightofuseasset": 30000,
    "assets": 81445000,
    "notespayablecurrent": 7953000,
    "operatingleaseliabilitycurrent": 530000,
    "financeleaseliabilitycurrent": 11000,
    "liabilitiescurrent": 8494000,
    "deferredrevenuenoncurrent": 35000000,
    "operatingleaseliabilitynoncurrent": 1553000,
    "financeleaseliabilitynoncurrent": 19000,
    "liabilities": 45066000,
    "commonstockvalue": 28000,
    "additionalpaidincapital": 373934000,
    "retainedearningsaccumulateddeficit": -337583000,
    "stockholdersequity": 36379000,
    "liabilitiesandstockholdersequity": 81445000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 694000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 50000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 1000000000,
    "commonstocksharesissued": 27634213,
    "commonstocksharesoutstanding": 27634213,
    "revenues": 81000,
    "researchanddevelopmentexpense": 38670000,
    "generalandadministrativeexpense": 13331000,
    "operatingexpenses": 52001000,
    "operatingincomeloss": -51920000,
    "interestincomeexpensenet": 3102000,
    "nonoperatingincomeexpense": 3102000,
    "netincomeloss": -48818000,
    "earningspersharebasic": -1.83,
    "weightedaveragenumberofsharesoutstandingbasic": 26604045,
    "earningspersharediluted": -1.83,
    "weightedaveragenumberofdilutedsharesoutstanding": 26604045,
    "stockissuedduringperiodvaluesharebasedcompensation": 3842000,
    "stockissuedduringperiodsharessharebasedcompensation": 13144,
    "stockissuedduringperiodvaluenewissues": 2000,
    "stockissuedduringperiodsharesnewissues": 1902005,
    "stockissuedduringperiodvaluestockoptionsexercised": 262000,
    "stockissuedduringperiodsharesstockoptionsexercised": 44241,
    "sharebasedcompensation": 3842000,
    "depreciationandamortization": 790000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -49000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -2177000,
    "increasedecreaseinoperatingleaserightofuseassets": -527000,
    "increasedecreaseinoperatingleaseliability": -494000,
    "netcashprovidedbyusedinoperatingactivities": -47335000,
    "paymentstoacquirepropertyplantandequipment": 153000,
    "netcashprovidedbyusedininvestingactivities": -153000,
    "financeleaseprincipalpayments": 4000,
    "proceedsfromissuanceofcommonstock": 14612000,
    "proceedsfromstockoptionsexercised": 262000,
    "netcashprovidedbyusedinfinancingactivities": 14870000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -32618000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 76990000,
    "rightofuseassetsobtainedinexchangeforleaseliabilities": 30000,
    "natureofbusinesspolicypolicytextblock": "<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in\"><b>Nature of Business â€“</b>Actinium Pharmaceuticals, Inc. is a biopharmaceutical company developing ARCs and other targeted radiotherapies to deliver cancer-killingradiation with cellular level precision to treat patients with high unmet medical needs.</p>",
    "scheduleordescriptionofweightedaveragetermtabletextblock": "Weighted average remaining lease terms are as followsat December 31, 2023:",
    "scheduleofweightedaveragediscountrate": "weighted average discount rates used at the time that the leases were evaluated:",
    "cashequivalentsatcarryingvalue": 76677000,
    "cashandcashequivalentsfairvaluedisclosure": 76990000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5445000,
    "prepaidinsurance": 614000,
    "otherprepaidexpensecurrent": 746000,
    "otherassetscurrent": 226000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentgross": 806000,
    "propertyplantandequipmentotheraccumulateddepreciation": 694000,
    "depreciation": 175000,
    "operatingleaseexpense": 691000,
    "financeleaserightofuseassetamortization": 3000,
    "leasecost": 3000,
    "operatingleasepayments": 606000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 30000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y7M6D",
    "financeleaseweightedaverageremainingleaseterm1": "P3Y",
    "operatingleaseweightedaveragediscountratepercent": 0.048,
    "financeleaseweightedaveragediscountratepercent": 0.062,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5445,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 373000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1438,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualtermgranted": "P7Y2M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 69000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2402,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.28,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 309,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 8.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 305000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 5.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 5000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 8.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionscancelledinperiod": 25000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionscancelledinperiodweightedaveragegrantdatefairvalue": 7.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaveragesremainingcontractualterm2": "P0Y4M2D",
    "weightedaverageremainingcontractualtermgranted": "P10Y",
    "stockissuedduringperiodsharesstockoptionscancelled": 3,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionscancelledinperiodweightedaverageexerciseprice": 106.8,
    "deferredtaxassetsoperatinglosscarryforwards": 41698000,
    "deferredrevenue": 8219000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 1512000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 20509000,
    "deferredtaxassetsgoodwillandintangibleassets": 18684000,
    "deferredtaxassetsother": -57000,
    "deferredtaxassetsvaluationallowance": 90566000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -10252000,
    "effectiveincometaxratereconciliationtaxexemptincome": 0.21,
    "incometaxreconciliationstateandlocalincometaxes": -1743000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.036,
    "incometaxreconciliationdeferredtrue-up": -176000,
    "effectiveincometaxreconciliationdeferredtrueups": 0.004,
    "incometaxreconciliationtaxcreditsresearch": 3263000,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.067,
    "incometaxreconciliationotheradjustments": 608000,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.012,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 14474000,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.297,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.05,
    "effectiveincometaxratereconciliationtaxcredits": 0.05,
    "lesseeoperatingleasedescription": "5years 2 months",
    "leaseexpirationdate1": "2027-07-30",
    "paymentsforrent": 600000,
    "landimprovements": 500000,
    "otherincome": 100000,
    "descriptionofroyaltypaymenttorelatedparty": "Upon commercial sale of the drug, royalty payments of 2% of net sales will be due to FHCRC.",
    "netsales": 0.02,
    "saleofstocknumberofsharesissuedintransaction": 1900000,
    "grossproceeds": 15100000,
    "warrantexercisepricedecrease": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P10Y",
    "fairvalueoptionaggregatedifferenceslongtermdebtinstruments": 9000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpurchasepriceofcommonstockpercent": 0.035,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.79,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 309000,
    "stockoptionsexercisedsharesofcommonstock": 44000,
    "unrecognizedcompensationexpense": 14400000,
    "weightedaverageterm": "P3Y4M24D",
    "compensationexpenserelatedtostockoptions": 3200000,
    "restrictedinvestmentsatfairvalue": 1800000,
    "compensationexpenserelatedtorsus": 600000,
    "exercisableperiodyears": "P5Y",
    "warrantexercisepriceincrease": 31.5,
    "allocatedsharebasedcompensationexpense": 6000,
    "deferredtaxassetsvaluationallowances": 90600000,
    "incometaxreconciliationtaxcontingenciesforeign": 165100000,
    "operatinglosscarryforwards": 104800000,
    "indefinitelivedcontractualrights": 60300000,
    "taxcreditcarryforwardlimitationsonuse": "limited to 80% of their value if used in a taxyear ending after January 1, 2023.",
    "incometaxreconciliationtaxcontingenciesstateandlocal": 283000000,
    "deferredtaxassetsinprocessresearchanddevelopment": 5100000,
    "taxcutsandjobsactof2017transitiontaxforcapitalizetheexpenditures": "P5Y",
    "researchanddevelopmentarrangementwithfederalgovernmentcostsincurrednet": 36900000,
    "accumulatedgrossamount": 79600000,
    "dividendscommonstockstock": 1800000,
    "netproceeds": 14700000,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "ACTINIUM PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1388320,
    "entityfilenumber": "001-36374",
    "entitytaxidentificationnumber": "74-2963609",
    "entityincorporationstatecountrycode": "DE",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityaddressaddressline1": "100 Park Ave., 23rd Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10017,
    "cityareacode": "(646)",
    "localphonenumber": "677-3870",
    "security12btitle": "Common stock, par value $0.001",
    "tradingsymbol": "ATNM",
    "securityexchangename": "NYSE",
    "auditorname": "Marcum llp",
    "auditorfirmid": 688,
    "auditorlocation": "Houston, Texas"
  },
  {
    "date": "2022-12-30",
    "symbol": "ATNM",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 108910000,
    "restrictedcashcurrent": 396000,
    "prepaidexpenseandotherassetscurrent": 1636000,
    "assetscurrent": 110942000,
    "propertyplantandequipmentnet": 604000,
    "restrictedcashnoncurrent": 302000,
    "operatingleaserightofuseasset": 2341000,
    "financeleaserightofuseasset": 3000,
    "assets": 114192000,
    "notespayablecurrent": 10130000,
    "operatingleaseliabilitycurrent": 494000,
    "financeleaseliabilitycurrent": 4000,
    "liabilitiescurrent": 10628000,
    "deferredrevenue": 35000000,
    "longtermoperatingleaseobligationsnoncurrent": 2083000,
    "liabilities": 47711000,
    "commonstockvalue": 26000,
    "additionalpaidincapital": 355220000,
    "retainedearningsaccumulateddeficit": -288765000,
    "stockholdersequity": 66481000,
    "liabilitiesandstockholdersequity": 114192000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 487000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 50000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 1000000000,
    "commonstocksharesissued": 25674823,
    "commonstocksharesoutstanding": 25674823,
    "subleaseincome": 1030000,
    "revenues": 1030000,
    "researchanddevelopmentexpense": 23135000,
    "generalandadministrativeexpense": 11999000,
    "operatingexpenses": 35134000,
    "operatingincomeloss": -34104000,
    "interestincomeexpensenet": 1087000,
    "nonoperatingincomeexpense": 1087000,
    "netincomeloss": -33017000,
    "earningspersharebasic": -1.37,
    "weightedaveragenumberofsharesoutstandingbasic": 24141545,
    "earningspersharediluted": -1.37,
    "weightedaveragenumberofdilutedsharesoutstanding": 24141545,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 66481000,
    "sharesoutstanding": 25674823,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 2795000,
    "stockissuedduringperiodsharessharebasedcompensation": 19639,
    "stockissuedduringperiodvalueother": 23158000,
    "stockissuedduringperiodsharesother": 3511210,
    "sharebasedcompensation": 2795000,
    "depreciationandamortization": 699000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 158000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 4595000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -998000,
    "increasedecreaseindeferredrevenue": 35000000,
    "increasedecreaseinoperatingleaseliabilities": -272000,
    "netcashprovidedbyusedinoperatingactivities": 8644000,
    "paymentstoacquirepropertyplantandequipment": 366000,
    "netcashprovidedbyusedininvestingactivities": -366000,
    "financeleaseprincipalpayments": 49000,
    "salesofsharesofcommonstocknetofcosts": 23158000,
    "netcashprovidedbyusedinfinancingactivities": 23109000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 31387000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 109608000,
    "rightofuseassetsobtainedinexchangeforleaseliabilities": 2605000,
    "acquisitionofequipmentfinancedbysecuritydeposit": 50000,
    "leasestextblock": "Note 4 - Leases Â ",
    "otherrevenuetextblock": "Note 5 - Other revenueÂ ",
    "natureofbusinesspolicytextblock": "Nature of Business - ActiniumPharmaceuticals, Inc. is a biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellularlevel precision to treat patients with high unmet medical needs.Â ",
    "scheduleordescriptionofweightedaverageterm": "      Weighted average remaining lease term:Â     Â       Operating leasesÂ     4.6 years      Finance LeasesÂ     1.0 years  Â ",
    "scheduleofweightedaveragediscountrate": "      Weighted average discount rates:Â     Â Â       Operating leasesÂ     Â 4.8%      Finance LeasesÂ     Â 8.0%  Â ",
    "operatingandfinanceleaseliabilitymaturitytabletextblock": "      Year ending December 31,Â     OperatingÂ  LeasesÂ Â     FinanceÂ  LeasesÂ       2023Â     Â 606Â Â     Â 4Â       2024Â     Â 618Â Â     Â -Â       2025Â     Â 630Â Â     Â -Â       2026Â     Â 643Â Â     Â -Â       2027Â     Â 380Â Â     Â -Â       Total lease paymentsÂ     $2,877Â Â     $4Â       Less imputed interestÂ     Â (300)Â     Â -Â       Present value of lease liabilitiesÂ     $2,577Â Â     $4Â   ",
    "cashequivalentsatcarryingvalue": 108910000,
    "otherrestrictedassetscurrent": 302000,
    "cashandcashequivalentsfairvaluedisclosure": 109608000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5164,
    "prepaidinsurance": 684000,
    "prepaidclinicaltrialexpenses": 887000,
    "otherprepaidexpensecurrent": 65000,
    "propertyplantandequipmentusefullife": 7,
    "propertyplantandequipmentgross": 315000,
    "propertyplantandequipmentotheraccumulateddepreciation": 487000,
    "depreciation": 152000,
    "operatingleaseexpense": 584000,
    "financeleaserightofuseassetamortization": 55000,
    "financeleaseinterestexpense": 2000,
    "operatingleasecost": 57000,
    "operatingleasepayments": 352000,
    "financeleaseinterestpaymentonliability": 2000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 2605000,
    "operatingleaseweightedaverageremainingleaseterm1": 4.6,
    "financeleaseweightedaverageremainingleaseterm1": 1,
    "operatingleaseweightedaveragediscountratepercent": 0.048,
    "financeleaseweightedaveragediscountratepercent": 0.08,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyeartwo": 4000,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearthree": 618000,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearfour": 630000,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearfive": 643000,
    "lesseeoperatingleaseliabilitypaymentsdueafterrollingyearfive": 380000,
    "lesseeoperatingleaseliabilitypaymentsdue": 4000,
    "paymentwithimputedinterestpremium": -300000,
    "maturitiesofleaseliabilities": 4000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3396,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 15204000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterms": 1.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1440,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 15.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualtermgranted": 7.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2432000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 2094,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": -669,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 15.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 5.96,
    "rsusoutstandingendingbalance": 325000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 325000,
    "numberofwarrantsoutstandings": 1443,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 16.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 5000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 1.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 4000,
    "weightedaverageexercisepricecancelled": 29.01,
    "deferredtaxassetsoperatinglosscarryforwards": 44233000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 1334000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 17247000,
    "deferredtaxassetsgoodwillandintangibleassets": 13210000,
    "deferredtaxassetsother": 69000,
    "deferredtaxassetsvaluationallowance": 76093000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -6943000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incometaxreconciliationstateandlocalincometaxes": -4863000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.147,
    "deferredtaxassetsnet": 89000,
    "effectiveincometaxreconciliationdeferredtrueups": 0.003,
    "researchanddevelopmentinprocess": 2711000,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.08199999999999999,
    "otheraccruedliabilitiescurrent": 934000,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.027999999999999997,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 13494000,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.408,
    "lesseeoperatingleasedescription": "5 years 2 months",
    "leasecost": 600000,
    "recognitionofdeferredrevenue1": 900000,
    "revenuerecognized": 100000,
    "longtermlicenserevenuedeferred": 35000000,
    "saleofstocknumberofsharesissuedintransaction": 3500000,
    "proceedsfromissuanceofcommonstock": 23900000,
    "proceedsfromissuanceorsaleofequity": 23200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 33333,
    "grantofstockoptionspurchaseshares": 2100000,
    "classofwarrantorrightexercisepriceofwarrantsorright": 13.54,
    "stockoptionterm": 10,
    "vestingperiodofstockoption": 4.2,
    "aggregatefairvalue": 7700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsdiscountforpostvestingrestrictions": 0.043,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8109999999999999,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 60000,
    "unrecognizedcompensationexpense": 1700000,
    "weightedaverageterm": 3.3,
    "compensationexpenserelatedtostockoptions": 2500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "three years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 2.4,
    "compensationexpenserelatedtorsus": 200000,
    "exercisableperiodyears": 5,
    "warrantexercisepriceincrease": 31.5,
    "allocatedsharebasedcompensationexpense": 6000,
    "deferredtaxassetsvaluationallowances": 76100000,
    "incometaxreconciliationtaxcontingenciesforeign": 178600000,
    "taxcreditcarryforwardlimitationsonuse": "NOLs of $118.4 million generated prior to 2018 will begin to expire if unused in 2023. NOLs generated in 2018 and lateryears of $60.2 million have an indefinite life, but will be limited to 80% of their value if used in a tax year ending after January 1,2023.",
    "incometaxreconciliationtaxcontingenciesstateandlocal": 271100000,
    "researchanddevelopmentarrangementwithfederalgovernmentcostsincurrednet": 3400000,
    "deferredincometaxesandtaxcredits": 13800000,
    "dividendscommonstockstock": 100000,
    "proceedsfromdebtnetofissuancecosts": 800000,
    "entityregistrantname": "ACTINIUM PHARMACEUTICALS, INC.",
    "tradingsymbol": "ATNM",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1388320,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31,2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "000-52446",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "74-2963609",
    "entityaddressaddressline1": "275 Madison Avenue, 7th Fl",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10016,
    "cityareacode": "(646)",
    "localphonenumber": "677-3870",
    "security12btitle": "Common stock, par value $0.001",
    "securityexchangename": "NYSE",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "Marcum llp",
    "auditorlocation": "Houston, Texas",
    "auditorfirmid": 688
  },
  {
    "date": "2021-12-30",
    "symbol": "ATNM",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 77829000,
    "restrictedcashcurrent": 392000,
    "securitydeposits": 50000,
    "prepaidexpenseandotherassetscurrent": 1478000,
    "assetscurrent": 79749000,
    "propertyplantandequipmentnet": 340000,
    "operatingleaserightofuseasset": 241000,
    "financeleaserightofuseasset": 58000,
    "assets": 80388000,
    "notespayablecurrent": 5535000,
    "otherliabilities": 998000,
    "operatingleaseliabilitycurrent": 245000,
    "financeleaseliabilitycurrent": 62000,
    "liabilitiescurrent": 6840000,
    "longtermfinanceleaseobligationsnoncurrent": 3000,
    "liabilities": 6843000,
    "commonstockvalue": 22000,
    "additionalpaidincapital": 329271000,
    "retainedearningsaccumulateddeficit": -255748000,
    "stockholdersequity": 73545000,
    "liabilitiesandstockholdersequity": 80388000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 335000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 50000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 1000000000,
    "commonstocksharesissued": 22143974,
    "commonstocksharesoutstanding": 22143974,
    "subleaseincome": 1144000,
    "revenues": 1144000,
    "researchanddevelopmentexpense": 18031000,
    "generalandadministrativeexpense": 8077000,
    "operatingexpenses": 26108000,
    "operatingincomeloss": -24964000,
    "interestincomeexpensenet": 190000,
    "nonoperatingincomeexpense": 190000,
    "profitloss": -24774000,
    "netincomelossavailabletocommonstockholdersbasic": -24774000,
    "earningspersharebasicanddiluted": -1.2,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 20568373,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 73545000,
    "sharesoutstanding": 22143974,
    "stockissuedduringperiodvaluesharebasedcompensation": 1694000,
    "stockissuedduringperiodsharessharebasedcompensation": 21306,
    "stockissuedduringperiodvalueother": 35300000,
    "stockissuedduringperiodsharesother": 4588875,
    "stockissuedduringperiodvaluestockoptionsexercisednetoftaxbenefitexpense": 6000,
    "issuanceofcommonstockfromexerciseofstockoptionsinshares": 900,
    "stockissuedduringperiodsharesstockoptionsexercised": 1,
    "netincomeloss": -24774000,
    "sharebasedcompensation": 1694000,
    "depreciationandamortization": 524000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 161000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 1195000,
    "increasedecreaseinothercurrentliabilities": 998000,
    "increasedecreaseinoperatingleaseliabilities": -342000,
    "netcashprovidedbyusedinoperatingactivities": -20866000,
    "paymentstoacquirepropertyplantandequipment": 133000,
    "netcashprovidedbyusedininvestingactivities": -133000,
    "financeleaseprincipalpayments": 85000,
    "proceedsfromissuanceofcommonstock": 35300000,
    "proceedsfromstockoptionsexercised": 6000,
    "netcashprovidedbyusedinfinancingactivities": 35221000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 14222000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 78221000,
    "leasestextblock": "Note4 - Leases Â ",
    "otherrevenuetextblock": "Note 5 - Other revenueÂ ",
    "scheduleofdepreciationexpensetabletextblock": "      Â Â     DecemberÂ 31,Â Â     DecemberÂ 31,Â       (in thousands)Â     2021Â Â     2020Â       ResearchÂ and developmentÂ     $88Â Â     $36Â       General administrativeÂ     Â 17Â Â     Â 18Â       Total Depreciation expenseÂ     $105Â Â     $54Â   ",
    "scheduleordescriptionofweightedaverageterm": "      Weighted average remaining lease term:Â     Â Â Â       Operating leasesÂ     Â 0.6 yearsÂ       Finance LeasesÂ     Â 0.8 yearsÂ   Â ",
    "scheduleofweightedaveragediscountrate": "      Weighted average discount rates:Â     Â Â       Operating leasesÂ     Â 8%      Finance LeasesÂ     Â 8%  Â ",
    "operatingandfinanceleaseliabilitymaturitytabletextblock": "      Year ending December 31,Â     OperatingÂ  LeasesÂ Â     FinanceÂ  LeasesÂ       2022Â     Â 252Â Â     Â 64Â       2023Â     Â -Â Â     Â 4Â       Total lease paymentsÂ     $252Â Â     $68Â       Less imputed interestÂ     Â (7)Â     Â (3)      Present value of lease liabilitiesÂ     $245Â Â     $65Â   ",
    "cashequivalentsatcarryingvalue": 77829000,
    "cashandcashequivalentsfairvaluedisclosure": 78221000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3474000,
    "prepaidinsurance": 874000,
    "prepaidclinicaltrialexpenses": 543000,
    "otherprepaidexpensecurrent": 61000,
    "propertyplantandequipmentusefullife": 7,
    "propertyplantandequipmentgross": 199000,
    "depreciation": 105000,
    "operatingleaseexpense": 372000,
    "financeleaserightofuseassetamortization": 81000,
    "financeleaseinterestexpense": 9000,
    "operatingleasecost": 90000,
    "operatingleasepayments": 377000,
    "financeleaseinterestpaymentonliability": 9000,
    "financingcashflowusefromfinanceleases": 85000,
    "operatingleaseweightedaverageremainingleaseterm1": 0.6,
    "financeleaseweightedaverageremainingleaseterm1": 0.8,
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "financeleaseweightedaveragediscountratepercent": 0.08,
    "maturitiesleaseliabilitypaymentsdueyeartwo": 64000,
    "maturitiesleaseliabilitypaymentsdueyearthree": 4000,
    "leaseliabilitypaymentsdue": 68000,
    "paymentwithimputedinterestpremium": -3000,
    "maturitiesofleaseliabilities": 65000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1362,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 12.45,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": 8.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 276000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2108000,
    "weightedaverageexercisepriceexercisableending": 27.04,
    "weightedaverageremainingcontractualterminyearsexercisableending": 6.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 881,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.3,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 2000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 50.17,
    "numberofwarrantsoutstandings": 2112000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 20.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 276000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterms": 1.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 20.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 1.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1000,
    "deferredtaxassetsoperatinglosscarryforwards": 36405000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1213000,
    "deferredtaxassetsinprocessresearchanddevelopment": 14536000,
    "deferredtaxassetsgoodwillandintangibleassets": 10426000,
    "deferredtaxassetsother": 19000,
    "deferredtaxassetsvaluationallowance": 62599000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -5202000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incometaxreconciliationstateandlocalincometaxes": -373000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.015,
    "incometaxreconciliationdeferredtrueup": 562000,
    "effectiveincometaxreconciliationdeferredtrueups": 0.023,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 1898000,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.077,
    "incometaxreconciliationotherreconcilingitems": 486000,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.02,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 6425000,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.259,
    "regulatedoperatingrevenueother": 200000,
    "costofrevenue": 900000,
    "deferredrevenuerevenuerecognized1": 1000000,
    "saleofstocknumberofsharesissuedintransaction": 4600000,
    "grossproceedsfromwarrantexercises": 36500000,
    "proceedsfromissuanceorsaleofequity": 35300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 758333,
    "stockrepurchasedduringperiodshares": 881000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 6.02,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 9.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 4.2,
    "aggregatefairvalue": 3900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 333000,
    "compensationexpenserelatedtostockoptions": 1500000,
    "stockbasedcompensationexpensewarrants": 16000,
    "deferredtaxassetvaluationallowance": 62600000,
    "incometaxreconciliationtaxcontingenciesforeign": 163000000,
    "taxcreditcarryforwardlimitationsonuse": "NOLs of $120.8 milliongenerated prior to 2018 will begin to expire if unused in 2022. NOLs generated in 2018 and later years of $42.2 million have an indefinitelife, but will be limited to 80% of their value if used in a tax year ending after January 1, 2022.",
    "operatinglosscarryforwardexpirationdate": "TheCompany has federal research and development tax credits of $2.9 million at December 31, 2021 which will begin to expire in 2034 if unusedand orphan drug credits of $11.6 million which will begin to expire in 2028 if unused.Â Â ",
    "operatinglosscarryforwards": 11600000,
    "entityregistrantname": "ACTINIUM PHARMACEUTICALS, INC.",
    "tradingsymbol": "ATNM",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1388320,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31,2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "000-52446",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "74-2963609",
    "entityaddressaddressline1": "275 Madison Avenue, 7th Fl.",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10016,
    "cityareacode": "(646)",
    "localphonenumber": "677-3870",
    "security12btitle": "Common stock, par value $0.001",
    "securityexchangename": "NYSE",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "Marcumllp",
    "auditorlocation": "Houston,Texas",
    "auditorfirmid": 688
  },
  {
    "date": "2020-12-30",
    "symbol": "ATNM",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 63560000,
    "restrictedcashcurrent": 48000,
    "prepaidexpenseandotherassetscurrent": 1317000,
    "assetscurrent": 64925000,
    "propertyplantandequipmentnet": 312000,
    "operatingleaserightofuseasset": 579000,
    "financeleaserightofuseasset": 140000,
    "securitydeposit": 50000,
    "restrictedcash": 391000,
    "assets": 66397000,
    "accountspayableandaccruedliabilitiescurrent": 4340000,
    "operatingleaseliabilitycurrent": 342000,
    "financeleaseliabilitycurrent": 85000,
    "liabilitiescurrent": 4767000,
    "longtermoperatingleaseobligationsnoncurrent": 245000,
    "longtermfinanceleaseobligationsnoncurrent": 66000,
    "liabilities": 5078000,
    "commonstockvalue": 18000,
    "additionalpaidincapital": 292275000,
    "retainedearningsaccumulateddeficit": -230974000,
    "stockholdersequity": -230974000,
    "liabilitiesandstockholdersequity": 66397000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 291000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 50000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 1000000000,
    "commonstocksharesissued": 17532893,
    "commonstocksharesoutstanding": 17532893,
    "researchanddevelopmentexpense": 16085000,
    "generalandadministrativeexpense": 6308000,
    "operatingexpenses": 22393000,
    "operatingincomeloss": -22393000,
    "interestincomeexpensenet": 178000,
    "nonoperatingincomeexpense": 178000,
    "netincomeloss": -22215000,
    "provisionofdeemeddividendforwarrantdownroundprotection": 1000,
    "netincomelossavailabletocommonstockholdersbasic": -22216000,
    "earningspersharebasicanddiluted": -1.83,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 12134259,
    "sharesoutstanding": 17532893,
    "stockissuedduringperiodvaluesharebasedcompensation": 1254000,
    "stockissuedduringperiodsharessharebasedcompensation": 6262,
    "stockissuedduringperiodvaluenewissues": 76589000,
    "stockissuedduringperiodsharesnewissues": 8575051,
    "issuanceofcommonstockfromexerciseofprefundedwarrantsvalue": 10000,
    "issuanceofcommonstockfromexerciseofprefundedwarrantsshares": 3458929,
    "stockissuedduringperiodvaluewarrantsexercised": 37000,
    "stockissuedduringperiodshareswarrantsexercised": 2613,
    "deemeddividendforwarrantdownroundprotectionprovision": -1000,
    "profitloss": -22215000,
    "sharebasedcompensation": 1254000,
    "depreciationandamortization": 447000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 531000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -257000,
    "increasedecreaseinotheroperatingcapitalnet": 315000,
    "netcashprovidedbyusedinoperatingactivities": -21617000,
    "paymentstoacquirepropertyplantandequipment": 253000,
    "netcashprovidedbyusedininvestingactivities": -253000,
    "repaymentsofnotespayable": 381000,
    "financeleaseprincipalpayments": 79000,
    "proceedsfromissuanceofcommonstock": 76589000,
    "proceedsfromissuanceofwarrants": 47000,
    "netcashprovidedbyusedinfinancingactivities": 76176000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 54306000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 63999000,
    "interestpaidnet": 8000,
    "stockissued1": 753000,
    "deemeddividendforwarrantsdownroundprotectionprovision": 1000,
    "otherrestrictedassetscurrent": 391000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2928000,
    "prepaidinsurance": 792000,
    "prepaidclinicaltrialexpenses": 457000,
    "otherprepaidexpensecurrent": 68000,
    "propertyplantandequipmentusefullife": "P7Y",
    "propertyplantandequipmentgross": 225000,
    "depreciation": 54000,
    "operatingleaseexpense": 372000,
    "financeleaserightofuseassetamortization": 81000,
    "financeleaseinterestexpense": 16000,
    "operatingleasecost": 97000,
    "operatingleasepayments": 375000,
    "financeleaseinterestpaymentonliability": 16000,
    "financingcashflowusefromfinanceleases": 78000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 83000,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y292D",
    "financeleaseweightedaverageremainingleaseterm1": "P1Y255D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "financeleaseweightedaveragediscountratepercent": 0.08,
    "maturitiesleaseliabilitypaymentsduenexttwelvemonths": 94000,
    "maturitiesleaseliabilitypaymentsdueyeartwo": 64000,
    "maturitiesleaseliabilitypaymentsdueyearthree": 4000,
    "leaseliabilitypaymentsdue": 162000,
    "paymentwithimputedinterestpremium": 11000,
    "maturitiesofleaseliabilities": 151000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 815000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 20.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 120000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterms": "P2Y277D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2111000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 20.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P2Y277D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 362000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3459000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.003,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 756000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 20.99,
    "stockissuedduringperiodsharesstockoptionsexercised": -2000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 15,
    "numberofwarrantoutstanding": 2113000,
    "aggregateintrinsicvalueending": 362000,
    "deferredtaxassetsoperatinglosscarryforwards": 33955000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1689000,
    "incometaxreconciliationresearchanddevelopment": 12638000,
    "deferredtaxassetsgoodwillandintangibleassets": 7873000,
    "deferredtaxassetsother": 19000,
    "deferredtaxassetsvaluationallowance": 56174000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -4665000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incometaxreconciliationstateandlocalincometaxes": 56000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.003,
    "incometaxreconciliationdeferredtrueup": -64000,
    "effectiveincometaxreconciliationdeferredtrueups": -0.003,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 1766000,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.08,
    "incometaxreconciliationotherreconcilingitems": 202000,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.009,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 6237000,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.281,
    "purchaseofmaterials": 200000,
    "issuanceofcommonstockshares": 700000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.003,
    "warranttopurchaseofcommonstock": 700000,
    "shareprice": 0.003,
    "grossproceedsfromwarrantexercises": 22600000,
    "saleofstocknumberofsharesissuedintransaction": 27000,
    "proceedsfromissuanceorsaleofequity": 2500000,
    "saleofstockconsiderationreceivedontransaction": 200000,
    "stockrepurchasedduringperiodshares": 458000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 6.63,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 12.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y73D",
    "fairvalueoption": 3200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "Variables used in the Black-Scholes option-pricing model include: (1) discount rate range from 0.34% to 0.56% (2) expected life of 6 years, (3) expected volatility range from 83.6% to 85.5%, and (4) zero expected dividends.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionscancelledinperiod": 23000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 4000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P3Y109D",
    "stockoptionplanexpense": 1200000,
    "deemeddividend": 1000,
    "compensationexpenserelatedtostockoptions": 13000,
    "deferredtaxassetvaluationallowance": 56200000,
    "incometaxreconciliationtaxcontingenciesforeign": 152000000,
    "taxcreditcarryforwardlimitationsonuse": "limited to 80% of their value if used in a tax year ending after January 1, 2021.",
    "incometaxreconciliationtaxcontingenciesstateandlocal": 81700000,
    "operatinglosscarryforwards": 10400000,
    "operatinglosscarryforwardsexpirationdate1": "expire in 2028",
    "numberofshares": 1700000,
    "issuanceofcommonstock": 14400000,
    "entityregistrantname": "Actinium Pharmaceuticals, Inc.",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1388320,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "000-52446",
    "entityincorporationstatecountrycode": "DE",
    "entityinteractivedatacurrent": "Yes"
  },
  {
    "date": "2019-12-30",
    "symbol": "ATNM",
    "period": "FY",
    "entityregistrantname": "Actinium Pharmaceuticals, Inc.",
    "entitycentralindexkey": 1388320,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "000-52446",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "DE",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "cashandcashequivalentsatcarryingvalue": 9253831,
    "restrictedcashcurrent": 48092,
    "prepaidexpenseandotherassetscurrent": 785715,
    "assetscurrent": 10087638,
    "propertyplantandequipmentnet": 113136,
    "operatingleaserightofuseasset": 1200000,
    "financeleaserightofuseasset": 300000,
    "securitydeposit": 49859,
    "restrictedcash": 391327,
    "assets": 11670407,
    "accountspayableandaccruedliabilitiescurrent": 4597824,
    "notespayablecurrent": 380545,
    "operatingleaseliabilitycurrent": 286532,
    "financeleaseliabilitycurrent": 78732,
    "liabilitiescurrent": 5343633,
    "longtermoperatingleaseobligationsnoncurrent": 531372,
    "longtermfinanceleaseobligationsnoncurrent": 150939,
    "liabilities": 6025944,
    "commonstockvalue": 164701,
    "additionalpaidincapital": 214237323,
    "retainedearningsaccumulateddeficit": -208757561,
    "stockholdersequity": -208757561,
    "liabilitiesandstockholdersequity": 11670407,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 237417,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 50000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 1000000000,
    "commonstocksharesissued": 164701167,
    "commonstocksharesoutstanding": 164701167,
    "researchanddevelopmentexpense": 16549693,
    "generalandadministrativeexpense": 5521754,
    "operatingexpenses": 22071447,
    "operatingincomeloss": -22071447,
    "interestincomeexpensenet": 172393,
    "nonoperatingincomeexpense": 172393,
    "netincomeloss": -21899054,
    "provisionofdeemeddividendforwarrantdownroundprotection": 1269,
    "netincomelossavailabletocommonstockholdersbasic": -21900323,
    "earningspersharebasicanddiluted": -0.15,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 149271633,
    "sharesoutstanding": 164701167,
    "stockissuedduringperiodvaluesharebasedcompensation": 1294313,
    "stockissuedduringperiodsharessharebasedcompensation": 394300,
    "stockissuedduringperiodvaluewarrantsexercised": 1501218,
    "stockissuedduringperiodshareswarrantsexercised": 2543756,
    "stockissuedduringperiodvalueother": 15886191,
    "stockissuedduringperiodsharesother": 46060067,
    "deemeddividendforwarrantdownroundprotectionprovision": -1269,
    "profitloss": -21899054,
    "sharebasedcompensation": 1294707,
    "depreciationandamortization": 420089,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -253335,
    "increasedecreaseinaccountspayableandaccruedliabilities": -1255740,
    "increasedecreaseinoperatingleaseliabilities": -274786,
    "netcashprovidedbyusedinoperatingactivities": -21461449,
    "paymentstoacquirepropertyplantandequipment": 63893,
    "netcashprovidedbyusedininvestingactivities": -63893,
    "repaymentsofnotespayable": 249239,
    "paymentstoacquirefinancereceivables": 72696,
    "proceedsfromissuanceofcommonstockandwarrantnet": 15932251,
    "proceedsfromwarrantexercises": 1503762,
    "netcashprovidedbyusedinfinancingactivities": 17114078,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -4411264,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 9693250,
    "interestpaidnet": 26547,
    "prepaidexpensesfinancedbyaccountspayableandnotespayable": 422828,
    "deemeddividendforwarrantdownroundprotectionprovisionnoncashinvestingandfinancingactivities": 1269,
    "otherrestrictedassetscurrent": 391327,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 86140575,
    "derivativeliabilitiescurrent": -15916,
    "prepaidinsurance": 479783,
    "prepaidclinicaltrialexpenses": 236096,
    "otherprepaidexpensecurrent": 69836,
    "renewedinsurancepolicy": 422828,
    "thirdpartypremiumfinancingdownpayment": 42283,
    "propertyplantandequipmentusefullife": "P7Y0M0D",
    "propertyplantandequipmentgross": 202651,
    "depreciation": 21746,
    "operatingleaseexpense": 369300,
    "financeleaserightofuseassetamortization": 81295,
    "financeleaseinterestexpense": 21562,
    "operatingleasecost": 102857,
    "operatingleasepayments": 355922,
    "financeleaseinterestpaymentonliability": 21562,
    "financeleaseprincipalpayments": 72696,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 807374,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 221073,
    "operatingleaseweightedaverageremainingleaseterm1": "P2Y8M12D",
    "financeleaseweightedaverageremainingleaseterm1": "P2Y8M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "financeleaseweightedaveragediscountratepercent": 0.08,
    "maturitiesleaseliabilitypaymentsduenexttwelvemonths": 94260,
    "maturitiesleaseliabilitypaymentsdueyeartwo": 94260,
    "maturitiesleaseliabilitypaymentsdueyearthree": 64144,
    "maturitiesleaseliabilitypaymentsdueyearfour": 3912,
    "leaseliabilitypaymentsdue": 256576,
    "paymentwithimputedinterestpremium": 26905,
    "maturitiesofleaseliabilities": 229671,
    "longtermdebtandcapitalleaseobligations": 900000,
    "capitalleaseobligationsnoncurrent": 300000,
    "longtermfinanceleaseobligations": 200000,
    "longtermfinanceleaseobligationsnetofcurrent": 100000,
    "issuedletterofcreditoflease": 390825,
    "operatingleasesfutureminimumpaymentsdue": 391327,
    "lesseeoperatingleasedescription": "The lease is for 5,790 square feet with an expiration date of September 6, 2022, with a current annual rate of $341,610 for the remaining life of the lease.",
    "developmentinprocess": 11900000,
    "researchanddevelopmentinprocess": 3100000,
    "purchaseofmaterials": 200000,
    "projectremainingcost": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 86140575,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 42900000,
    "stockissuedduringperiodsharesstockoptionsexercised": 2543826,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 10036475,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 85928076,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 0.69,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.5,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.59,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 0.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P2Y0M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterms": "P2Y11M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P2Y11M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 301092,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 301092,
    "stockrepurchasedduringperiodshares": 5800000,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 0.2146,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 0.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The options have an aggregated fair value of $1.1 million that was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate range from 1.38% to 2.6% (2) expected life of 6 years, (3) expected volatility range from 78.5% to 81.8%, and (4) zero expected dividends.",
    "saleofstockconsiderationreceivedontransaction": 100000,
    "saleofstocknumberofsharesissuedintransaction": 400000,
    "allocatedsharebasedcompensationexpense": 100000,
    "proceedsfromissuanceorsaleofequity": 800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharespurchasedforaward": 1700000,
    "stockoptionplanexpense": 1200000,
    "warrantsexercisedbywarrantholders": 2500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 2100000,
    "stockissuedduringperiodsharesissuedforservices": 400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P8Y22D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalsharesgranted": 400000,
    "restrictedcommonsharesgranted": 400000,
    "restrictedcommonsharesgrantedvalue": 100000,
    "yettoissuecommonsharesforrestrictedsharesvested": 300000,
    "warrantexpired": 5000000,
    "increaseinshares": 1000000000,
    "stockoptionplandescription": "The 2019 Stock Plan as authorized, if implemented, would have 10.0 million shares to be issued. As of the date of this report, the 2019 Stock Plan has not been implemented.",
    "deferredtaxassetsoperatinglosscarryforwards": 31688387,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1421701,
    "incometaxreconciliationresearchanddevelopment": 10871634,
    "deferredtaxassetsgoodwillandintangibleassets": 5942126,
    "deferredtaxassetsother": 13172,
    "deferredtaxassetsvaluationallowance": 49937020,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -4598801,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incometaxreconciliationstateandlocalincometaxes": 1076602,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.049,
    "incometaxreconciliationdeferredtrueup": 1809913,
    "effectiveincometaxreconciliationdeferredtrueups": 0.083,
    "incometaxreconciliationnondeductibleexpenseresearchanddevelopment": 1974931,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.09,
    "incometaxreconciliationotherreconcilingitems": 144725,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.006,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 3542492,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.162,
    "operatinglosscarryforwards": 9100000,
    "operatinglosscarryforwardsexpirationdate": "2033-12-31",
    "deferredtaxassetvaluationallowance": 49900000,
    "incometaxreconciliationtaxcontingenciesstateandlocal": 71500000,
    "incometaxreconciliationtaxcontingenciesforeign": 140600000,
    "numberofshares": 800000,
    "proceedsfromissuanceofcommonstock": 200000
  }
]